Heartflow, Inc.

HTFL | Nasdaq | CIK: 0001464521 | SIC: 3841 Surgical & Medical Instruments & Apparatus | active
Heartflow, Inc. provides AI-powered software for diagnosing and managing coronary artery disease (CAD). Its Heartflow Platform uses deep learning and computational fluid dynamics applied to coronary CT angiography (CCTA) images to generate personalized 3D heart models. Products include Heartflow FFR CT Analysis, Heartflow Plaque Analysis, and Heartflow RoadMap Analysis. As of December 31, 2025, the platform has assessed CAD in over 600,000 patients across more than 1,465 U.S. accounts.
cardiovascular-diagnosticscoronary-artery-disease-managementmedical-ai-softwareradiology-workflow-optimizationaha-and-acc-class-1,-level-a-chest-pain-guidelinescoronary-computed-tomography-angiography-(ccta)computational-fluid-dynamicsdeep-learning-/-ai
AI agents: Get this data as structured JSON (~200 tokens):
https://origin.rootz.global/api/company/HTFL
Profile | Timeline | SEC Filings | People

Products

NameTypeDescription
Heartflow RoadMap AnalysissoftwareFDA-cleared anatomic visualization tool that improves CCTA read times by 25% and increases consistency between reviewing physicians by ~40%.
Heartflow FFR CT AnalysissoftwareFlagship product providing patient-specific interactive 3D coronary artery reconstruction with blood flow quantification derived from a single CCTA scan.
Heartflow Plaque AnalysissoftwareSoftware product that quantifies plaque volume and characterizes plaque composition from CCTA images to support risk stratification and treatment planning.

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/HTFL/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub